This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
electric-vehicles: Archive
Can Monolithic Power's Improved Automotive Solutions Drive Growth?
by Arijit Sarkar
MPWR's auto revenues rise 5.1% to $152.4M in Q1 2026, nearly 19% of total revenues, targeting EVs, ADAS and infotainment.
ADINegative Net Change MCHPPositive Net Change MPWRNegative Net Change
autonomous-vehicles electric-vehicles self-driving-cars semiconductor tech-stocks
Here's How to Approach Aeva Stock After Q1 Earnings Release
by Zacks Equity Research
AEVA gains traction with NVIDIA integration, OEM LiDAR programs and expanding AI, trucking and smart infrastructure opportunities.
PIIPositive Net Change PLOWPositive Net Change AEVAPositive Net Change PHINPositive Net Change
auto-tires-trucks electric-vehicles
Can Tesla's $250M Berlin Expansion Strengthen Its EV Lead?
by Zacks Equity Research
TSLA's $250 million Berlin expansion boosts battery output, adds 1,500 jobs and supports plans to raise EV production in Europe.
TSLANegative Net Change PIIPositive Net Change PLOWPositive Net Change PHINPositive Net Change
auto-tires-trucks electric-vehicles
Do Lumpy Q1 Deployments Undermine Tesla's Energy Momentum?
by Rimmi Singhi
Lumpy quarterly deployments weigh on TSLA's energy storage volumes, but management expects full-year growth and long-term momentum to be strong.
FPositive Net Change GMPositive Net Change TSLANegative Net Change
auto-tires-trucks electric-vehicles
NXP Semiconductors (NXPI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NXPINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Urogen Pharma (URGN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
URGNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
3 Original Auto Equipment Stocks to Consider Amid Weakening Demand
by Lavina Shahu
GTX, PHIN and LCII stand out in a weak auto equipment market with innovation, aftermarket growth and diversified operations.
GTXPositive Net Change LCIIPositive Net Change PHINPositive Net Change
auto-tires-trucks electric-vehicles
Can Ford Reduce Cyclical Risks Through Software & Services Growth?
by Lavina Shahu
F targets steadier profits by growing software and services revenues, with parts and remote repairs helping offset vehicle sales swings.
FPositive Net Change GMPositive Net Change TSLANegative Net Change
auto-tires-trucks electric-vehicles
Why Is Ford Cautious on Cash Flow Growth Despite Strong EBIT?
by Lavina Shahu
F posts stronger Q1 EBIT but keeps 2026 cash flow guidance unchanged amid tariff uncertainty and seasonal working capital pressures.
FPositive Net Change GMPositive Net Change TSLANegative Net Change
auto-tires-trucks electric-vehicles
Kforce (KFRC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
KFRCPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines